These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 2960421
1. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats. Henry JM, Joseph JA, Kochman K, Roth GS. Brain Res; 1987 Aug 25; 418(2):334-42. PubMed ID: 2960421 [Abstract] [Full Text] [Related]
2. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade. Henry JM, Roth GS. Life Sci; 1984 Aug 20; 35(8):899-904. PubMed ID: 6482680 [Abstract] [Full Text] [Related]
3. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O, Biggio G. Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234 [Abstract] [Full Text] [Related]
4. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ). Kula NS, George T, Baldessarini RJ. Brain Res Dev Brain Res; 1992 Apr 24; 66(2):286-9. PubMed ID: 1535031 [Abstract] [Full Text] [Related]
5. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. Hess EJ, Norman AB, Creese I. J Neurosci; 1988 Jul 24; 8(7):2361-70. PubMed ID: 2907912 [Abstract] [Full Text] [Related]
6. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms. Norman AB, Battaglia G, Creese I. J Neurosci; 1987 May 24; 7(5):1484-91. PubMed ID: 2952771 [Abstract] [Full Text] [Related]
7. Reduction of motor behavioural deficits in senescence via chronic prolactin or estrogen administration: time course and putative mechanisms of action. Joseph JA, Kochman K, Roth GS. Brain Res; 1989 Dec 29; 505(2):195-202. PubMed ID: 2532056 [Abstract] [Full Text] [Related]
11. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ. Crawford CA, Rowlett JK, McDougall SA, Bardo MT. Eur J Pharmacol; 1994 Feb 03; 252(2):225-31. PubMed ID: 8157063 [Abstract] [Full Text] [Related]
14. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Lévesque D, Di Paolo T. Mol Pharmacol; 1991 May 03; 39(5):659-65. PubMed ID: 1674586 [Abstract] [Full Text] [Related]
15. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum. Fuxe K, Meller E, Goldstein M, Benfenati F, Agnati LF. Neurosci Lett; 1986 Feb 28; 64(2):163-8. PubMed ID: 3960398 [Abstract] [Full Text] [Related]
16. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions. Giorgi O, Biggio G. Pharmacol Biochem Behav; 1990 Apr 28; 35(4):877-84. PubMed ID: 1971721 [Abstract] [Full Text] [Related]
17. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats. Ekman A, Eriksson E. Life Sci; 1991 Apr 28; 48(4):321-31. PubMed ID: 1824955 [Abstract] [Full Text] [Related]
18. A full repetitive jaw movement response after 70% depletion of caudate D1 receptors. Rosengarten H, Schweitzer JW, Friedhoff AJ. Pharmacol Biochem Behav; 1989 Dec 28; 34(4):895-7. PubMed ID: 2533692 [Abstract] [Full Text] [Related]
19. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors. Qin ZH, Chen JF, Weiss B. J Neurochem; 1994 Feb 28; 62(2):411-20. PubMed ID: 8294904 [Abstract] [Full Text] [Related]
20. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Hamblin MW, Creese I. Life Sci; 1983 May 09; 32(19):2247-55. PubMed ID: 6133202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]